STAT3 and non-small cell lung carcinoma: Our results suggest that cinobufagin can inhibit the STAT3 signaling pathway in NSCLC, thereby inducing cell apoptosis and suppressing cell proliferation, migration, and tumor growth (in an NSCLC xenograft model).